Industry News
Novel approach helps prevent early menopause in breast cancer patients, study finds
3/07/2015
Drug also may protect fertility in women hoping to have childrenEarly menopause can be prevented and fertility may be preserved in young women with early stage breast cancer, according to a study...
Nanoparticles carry drugs selectively to lung tumor sites
3/06/2015
Scientists have created nanocarriers that can selectively deliver chemotherapy drugs locally to lung tumor sites without touching healthy tissue, potentially reducing side effects.
Nanoparticles carry drugs selectively to lung tumor sites
3/06/2015
Scientists have created nanocarriers that can selectively deliver chemotherapy drugs locally to lung tumor sites without touching healthy tissue, potentially reducing side effects.
Myriad publishes myPath Melanoma pivotal validation study
3/06/2015
Myriad Genetics, Inc. has announced the Journal of Cutaneous Pathology published data from a pivotal clinical validation study that showed the myPath Melanoma test is highly effective at...
FDA expands approved use of Opdivo to treat lung cancer
3/06/2015
The U.S. Food and Drug Administration has expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression...
Combination cell-gene therapy for lung cancer to be tested in UK patients
3/06/2015
A pioneering new combined cell-gene therapy to treat lung cancer will be tested in NHS patients this year, after receiving £2m of Biomedical Catalyst funding from the Medical Research Council...
Scientists discover new roles for viral genes in the human genome
3/06/2015
The human genome is the blueprint for human life, but much of this blueprint still remains a mystery.
Under our nose: supplemental oxygen can make tumors shrink, says new study
3/06/2015
A method of profoundly enhancing some cancer treatments could be right under our noses.
Myriad publishes myPath Melanoma pivotal validation study
3/06/2015
Myriad Genetics, Inc. has announced the Journal of Cutaneous Pathology published data from a pivotal clinical validation study that showed the myPath Melanoma test is highly effective at...
FDA expands approved use of Opdivo to treat lung cancer
3/06/2015
The U.S. Food and Drug Administration has expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression...